DrugDashboards

Lisdexamfetamine Dimesylate

Lisdexamfetamine Dimesylate · LISDEXAMFETAMINE DIMESYLATE 30 mg/1 · Capsule · Oral · Bryant Ranch Prepack

NDC 72162-2454-01 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “shortage of an active ingredient”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00527-4663-37) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$5.48per unit
middle half $4.50–$7.13 · 2,437 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $5.48
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
44%of plans cover it
tier 4 · prior auth 11% · step therapy 1% · qty limit 59%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for lisdexamfetamine dimesylate (oral solid) in the next 90 days

7 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA215330
TE code
AB
Approval date
Aug 25, 2023
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)Jan 11, 2024
    Shortage of an active ingredient
    month 32 — 2× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)Nov 1, 2023
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)Nov 1, 2023
    Delay in shipping of the drug
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)Nov 1, 2023
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)Nov 1, 2023
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)Nov 1, 2023
    Delay in shipping of the drug
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)Nov 1, 2023
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)Nov 1, 2023
    month 35 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)Sep 20, 2023
    month 36 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)Jul 14, 2023
    Other
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)Jul 14, 2023
    month 38 — 3× the typical 14-month oral solid shortage · model puts 27% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lisdexamfetamine Dimesylate (Capsule)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 3, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 70 mg/1Jul 15, 2026Sep 2, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 10 mg/1Jul 15, 2026Sep 2, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Alvogen Inc.LISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingLISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingLISDEXAMFETAMINE DIMESYLATE 70 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingLISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingLISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingLISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingLISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 70 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 10 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 70 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 10 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 10 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LISDEXAMFETAMINE DIMESYLATE 70 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.LISDEXAMFETAMINE DIMESYLATE 10 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.LISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.LISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.LISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.LISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 2, 2026
Elite Laboratories, Inc.LISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lisdexamfetamine Dimesylate — NDC 72162-2454-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72162245401.

Free to cite with attribution — see how the data is put together.